Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRSN | BMY | AMGN | GILD | GSK |
| Company | Neurosense Therapeutics Ltd | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.3300 | 49.41 | 333.93 | 83.37 | 42.84 |
| High | 1.3650 | 50.18 | 339.00 | 84.52 | 42.90 |
| Low | 1.3100 | 48.78 | 331.00 | 82.76 | 42.49 |
| Last | 1.3300 | 49.75 | 333.73 | 83.84 | 42.54 |
| Change | -0.0100 | +0.26 | +0.93 | +0.79 | -0.02 |
| % Change | -0.75% | +0.53% | +0.28% | +0.95% | -0.05% |
| Volume | 74,726 | 4,445,813 | 805,479 | 6,256,882 | 2,703,910 |
| 20-Day Average Volume | 404,526 | 8,374,951 | 1,705,865 | 6,279,844 | 3,497,070 |
| Previous Close | 1.3400 | 49.49 | 332.80 | 83.05 | 42.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0180 | 49.07 | 329.28 | 79.65 | 43.29 |
| 20-Day Raw Stochastic | 84.02% | 78.53% | 74.24% | 93.36% | 28.79% |
| 20-Day Relative Strength | 71.18% | 58.21% | 55.89% | 72.45% | 51.98% |
| Weighted Alpha | -12.62 | -8.94 | +25.92 | +18.86 | +13.48 |
| Today's Opinion | 24% Buy | 72% Buy | 88% Buy | 88% Buy | 56% Buy |
| Previous Opinion | 8% Buy | 72% Buy | 88% Buy | 88% Buy | 56% Buy |
| Last Month's Opinion | 72% Sell | 24% Buy | 72% Buy | 40% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.02% since 09/11/24 | +2.74% since 09/11/24 | +1.13% since 09/11/24 | +4.05% since 09/11/24 | -2.78% since 09/11/24 |
| Low | 1.1900 on 09/13/24 | 47.76 on 09/12/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 42.44 on 09/17/24 |
| High | 1.4550 on 09/16/24 | 50.41 on 09/17/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 43.62 on 09/16/24 |
| 1-Month | |||||
| %Chg | +72.73% since 08/16/24 | +1.13% since 08/16/24 | +3.81% since 08/16/24 | +14.15% since 08/16/24 | +3.09% since 08/16/24 |
| Low | 0.6729 on 08/28/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 41.28 on 08/19/24 |
| High | 1.4550 on 09/16/24 | 50.75 on 09/04/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 44.67 on 08/27/24 |
| 3-Month | |||||
| %Chg | +44.57% since 06/18/24 | +22.32% since 06/18/24 | +9.06% since 06/18/24 | +33.37% since 06/18/24 | +3.92% since 06/18/24 |
| Low | 0.5120 on 07/19/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 37.81 on 07/02/24 |
| High | 1.5000 on 07/02/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 44.67 on 08/27/24 |
| 6-Month | |||||
| %Chg | -5.34% since 03/18/24 | -3.24% since 03/18/24 | +23.18% since 03/18/24 | +14.96% since 03/18/24 | +0.98% since 03/18/24 |
| Low | 0.5120 on 07/19/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 37.81 on 07/02/24 |
| High | 2.2500 on 04/04/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,312 | 100,321,184 | 178,525,568 | 103,468,096 | 88,204,832 |
| Shares Outstanding, K | 13,666 | 2,027,100 | 536,435 | 1,245,853 | 2,072,482 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 37,725,000,000 |
| Annual Net Income | -11,280,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 9,950,400,000 |
| Last Quarter Net Income | -5,400,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,480,440,000 |
| 60-Month Beta | 1.52 | 0.46 | 0.61 | 0.18 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 06/24/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 1.09 on 07/31/24 |
| Latest Earnings Date | 09/18/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/06/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | 0.378 on 08/16/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | 08/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.49 | 18.02 | 17.69 | 10.47 |